FDA
- Status: approved
Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Eskisehir Osmangazi University is the originator. The local marketing authorisation holder may differ — check the official source linked above.